The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Brand
ProteoGenix
Size
96T
Reference
KPTX233
Note
For research use only.
Sample type
Plasma, Serum
Immunogen
Lirilumab
Description of Lirilumab ELISA Kit
The Structure of Lirilumab ELISA Kit
Lirilumab ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) kit designed for the quantitative measurement of Lirilumab in various biological samples. Lirilumab is a human monoclonal antibody that targets the inhibitory killer cell immunoglobulin-like receptor (KIR) on natural killer (NK) cells.
The kit is composed of several components including a microplate coated with a specific antibody against Lirilumab, a detection antibody labeled with an enzyme, and a substrate solution. The microplate is divided into several wells, each of which is coated with the capture antibody. When a sample containing Lirilumab is added to the wells, the antibody binds to the Lirilumab, forming a sandwich complex. The detection antibody, which is specific for a different epitope on Lirilumab, is then added and binds to the Lirilumab in the sandwich complex. The enzyme-labeled detection antibody allows for the quantification of Lirilumab through a colorimetric reaction.
The Activity of Lirilumab ELISA Kit
Lirilumab ELISA Kit is a highly sensitive and specific tool for the detection and quantification of Lirilumab in various biological samples. It has a detection range of 0.1-10 ng/mL and a sensitivity of 0.05 ng/mL, making it a highly accurate and reliable method for measuring Lirilumab levels.
The kit is designed to specifically detect Lirilumab and does not cross-react with other related antibodies, ensuring the accuracy of the results. The enzyme-labeled detection antibody provides a highly sensitive and specific signal, allowing for the accurate quantification of Lirilumab even in low concentrations.
The Application of Lirilumab ELISA Kit
Lirilumab ELISA Kit has a wide range of applications in both research and clinical settings. It can be used for the detection and quantification of Lirilumab in various biological samples, including serum, plasma, and cell culture supernatants.
In research, the kit can be used to study the expression and activity of Lirilumab in different disease states. It can also be used to investigate the role of Lirilumab in the immune response and its potential as a therapeutic target.
In a clinical setting, Lirilumab ELISA Kit can be used for the monitoring of Lirilumab levels in patients receiving Lirilumab therapy. It can also aid in the diagnosis and prognosis of diseases where Lirilumab is involved, such as cancer and autoimmune disorders.
The Role of Lirilumab as a Therapeutic Target
Lirilumab is a promising therapeutic target in the treatment of various diseases, especially cancer. It works by blocking the inhibitory KIR on NK cells, allowing for the activation and proliferation of these immune cells. This leads to enhanced anti-tumor activity and can potentially improve the response to other cancer therapies.
The use of Lirilumab ELISA Kit in the monitoring of Lirilumab levels in patients undergoing Lirilumab therapy can provide valuable information on the efficacy of the treatment and help guide treatment decisions.
In conclusion, Lirilumab ELISA Kit is a highly sensitive and specific tool for the detection and quantification of Lirilumab, a promising therapeutic target in the treatment of various diseases. Its accurate and reliable results make it a valuable tool for both research and clinical applications.
Reviews
There are no reviews yet.